North America Pharmaceutical Excipients Market

The North America pharmaceutical excipients market is expected to grow from US$ 3,715.72 million in 2022 to US$ 5,326.59 million by 2028. It is estimated to register a CAGR of 6.2% from 2022 to 2028.

Increasing Product Launches is fueling the growth of North America pharmaceutical excipients market

The pharmaceutical excipients market is characterized by the presence of large and small market players. A few product launches have taken place in recent years. For instance, in October 2022, Rouqette, a pharmaceutical and nutraceutical excipients provider, launched two next-generation mannitol products—PEARLITOL CR-H and PEARLITOL 200 GT— for direct compression. These excipients have been specially formulated to overcome the unique drug formulation challenges in the pharmaceutical spaces, which helps the manufacturers optimize direct compression processes and expand into application areas such as mini tabs and controlled-release tablets. Similarly, in March 2022, Lubrizol Life Science Health launched Apisolex, a novel solubility-enhancing excipient for parenteral drug products. With the ability to improve solubility by up to 50,000-fold and support high drug loading, Apisolex excipient provides access to new and improved parenteral drug products. This is especially relevant in oncology, as direct injection of drugs into the bloodstream ensures higher bioavailability and lower patient variability compared to oral delivery. Similarly, in April 2021, DFE Pharma, the pharmaceutical excipient solution provider, launched its new product line, BioHale, a solution for biopharmaceutical manufacturers. With the launch of BioHale Sucrose, DFE Pharma offers exceptional market purity and low endotoxin excipient to be used in the formulation. The active participation of market players in product innovation and development, leading to the increase in product launches, is fueling the growth of the North America pharmaceutical excipients market.

North America Pharmaceutical Excipients Market Overview

The North America pharmaceutical excipients market is segmented into the US, Canada, and Mexico. The US held the largest share of the North American pharmaceutical excipients market in 2021. In North America, economic prosperity and a rise in demand for pharmaceuticals have boosted drug production. Consequently, excipient consumption is a key factor driving a gradual increase in manufacturing expenditures. Within the pharmaceutical industry, the falling price pressure lowered R&D productivity, and stringent regulations have prompted drug manufacturers to progressively turn to produce excipients with the intent to develop differentiated and value-adding products at low prices without compromising quality. The pharmaceutical industry has continuously been one of the most advanced research and development industries in the US. According to the International Trade Administration report in 2016, the research-based industry generally allocates ~15–20% of revenues to R&D activities and invests over US$ 50 billion in R&D annually. The US remains the global leader in innovative R&D investment. Thus, the research activities that fuel new drug manufacturing have a positive impact on the use of pharmaceutical excipients in dosage forms.

North America Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)

North America Pharmaceutical Excipients Strategic Insights

Strategic insights for the North America Pharmaceutical Excipients provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Pharmaceutical Excipients Report Scope

North America Pharmaceutical Excipients Regional Insights

The geographic scope of the North America Pharmaceutical Excipients refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Pharmaceutical Excipients Market Segmentation

The North America pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country. Based on type, the North America pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The inorganic chemicals segment registered the largest market share in 2022.

Based on clinical indication, the North America pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.

Based on functionality, the North America pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.

Based on application, the North America pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.

Based on end user, the North America pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.

Based on country, the North America pharmaceutical excipients market is segmented into the US, Canada, and Mexico. The US dominated the market in 2022.

Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the North America pharmaceutical excipients market.